Skip to content
Wealthy Investor Report

Wealthy Investor Report

  • Home
  • Domestic
  • Business
  • Money
  • Top News
  • Newsletters

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File Photo

Post navigation

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows

Recent Posts

  • 2 Healthcare Stocks That Can Diversify a Tech
  • Ignore the Noise: 3 AI Stocks Set to Surge 200% by the End of the Decade
  • Defense Stocks Rally as Trump Calls for Higher Military Budget
  • These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
  • FEPI Somehow Gives You 25% Income Off Big Tech Stocks That Hardly Pay Dividends

Categories

  • Business
  • Domestic
  • Economy
  • Latest News
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized
  • Privacy Policy of GBM Media Group, LLC
  • Terms of Service/Use Agreement
  • Disclaimer
  • Contact Us

Copyright © 2026 Wealthy Investor Report | Visionary News by Ascendoor | Powered by WordPress.